{"disease":{"id":"hyperhidrosis","name":"Hyperhidrosis","therapeutic_area":"","data":{},"enrichment_level":0,"last_enriched_at":null,"visit_count":0,"created_at":"2026-04-19T18:31:21.150Z","updated_at":"2026-04-19T18:39:44.960Z","meddra_pt":null,"meddra_code":null,"icd10_codes":null,"synonyms":[],"prevalence_global":null,"prevalence_us":null,"marketed_drug_count":3,"pipeline_drug_count":0,"trial_count":0},"drugs":{"marketed":[{"drug_id":"onabotulinumtoxina","indication_name":"Severe Axillary Hyperhidrosis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Botox","generic_name":"ONABOTULINUMTOXINA","company_name":"Allergan","drug_phase":"marketed","molecular_target":"SNAP-25","drug_class":"Acetylcholine Release Inhibitor [EPC]","quality_score":60,"revenue":"5300","mechanism":"BOTOX blocks neuromuscular transmission by inhibiting acetylcholine release through cleavage of SNAP-25."},{"drug_id":"sofpironium-bromide","indication_name":"Hyperhidrosis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Ecclock","generic_name":"SOFPIRONIUM BROMIDE","company_name":"Kaken Pharmaceutical","drug_phase":"marketed","molecular_target":"Muscarinic acetylcholine receptor M3","drug_class":"","quality_score":55,"revenue":null,"mechanism":"Ecclock works by blocking the muscarinic acetylcholine receptor M3, which reduces sweat gland activity."},{"drug_id":"glycopyrronium-bromide","indication_name":"Hyperhidrosis of axilla","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Cuvposa","generic_name":"GLYCOPYRRONIUM BROMIDE","company_name":"Shionogi","drug_phase":"marketed","molecular_target":"Muscarinic acetylcholine receptor M1","drug_class":"Anticholinergic","quality_score":62,"revenue":null,"mechanism":"Cuvposa works by blocking the action of a chemical called acetylcholine, which stimulates the muscarinic receptors in the body."},{"drug_id":"glycopyrrolate","indication_name":"Hyperhidrosis of axilla","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Glycopyrrolate","company_name":"Yonsei University","drug_phase":"marketed","molecular_target":"Muscarinic acetylcholine receptor M1, Muscarinic acetylcholine receptor M2, Muscarinic acetylcholine receptor M3","drug_class":"","quality_score":19,"revenue":null,"mechanism":null},{"drug_id":"aluminium-chlorohydrate","indication_name":"Hyperhidrosis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Aluminum Chlorhydrate","generic_name":"aluminium chlorohydrate","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"aluminium chlorohydrate","quality_score":19,"revenue":null,"mechanism":""},{"drug_id":"oxybutynin","indication_name":"Hyperhidrosis of palms","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Ditropan Xl","generic_name":"OXYBUTYNIN","company_name":"Hisamitsu Pharmaceutical Co., Inc.","drug_phase":"marketed","molecular_target":"Muscarinic acetylcholine receptor M3","drug_class":"Cholinergic Muscarinic Antagonist","quality_score":75,"revenue":null,"mechanism":"Oxybutynin works by blocking the action of a chemical called acetylcholine on the bladder muscle, reducing spasms and urgency."},{"drug_id":"sialanar","indication_name":"Hyperhidrosis of axilla","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Sialanar","company_name":"Proveca Pharma Limited","drug_phase":"marketed","molecular_target":"Muscarinic acetylcholine receptor M1, Muscarinic acetylcholine receptor M2, Muscarinic acetylcholine receptor M3","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"aluminium-chloride","indication_name":"Hyperhidrosis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Aluminum Chloride","generic_name":"aluminium chloride","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"aluminium chloride","quality_score":18,"revenue":null,"mechanism":""},{"drug_id":"oxytrol","indication_name":"Hyperhidrosis of palms","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Oxytrol","company_name":"Jewish General Hospital","drug_phase":"marketed","molecular_target":"Cytochrome P450 2C19, 5-hydroxytryptamine receptor 2B, D(3) dopamine receptor","drug_class":"","quality_score":null,"revenue":null,"mechanism":null}],"pipeline":[],"offLabel":[],"totalMarketed":9,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05247333","title":"Implementation of a Minor Ailment Service in Community Pharmacy Practice","phase":"NA","overall_status":"COMPLETED","enrollment_count":20987,"lead_sponsor_name":"Universidad de Granada","has_results":false},{"nct_id":"NCT03658616","title":"Assessment of Efficacy and Safety of Topical Administration of 1% Glycopyrronium Bromide (GPB) in Patients With Primary Axillary Hyperhidrosis and the Assessment of Long-term Efficacy and Safety of Topical Administration of 1% GPB Cream in Patients With Primary Axillary Hyperhidrosis.","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":518,"lead_sponsor_name":"Dr. August Wolff GmbH & Co. KG Arzneimittel","has_results":false},{"nct_id":"NCT06113978","title":"Thoracoscopic Sympathetic Chain Interruption for Palmar Hyperhidrosis in Patients Below 18","phase":"NA","overall_status":"COMPLETED","enrollment_count":420,"lead_sponsor_name":"dr. Muhammad Abdelhafez Mahmoud, MD","has_results":false},{"nct_id":"NCT03948646","title":"Safety and Efficacy Study of Sofpironium Bromide in Subjects With Axillary Hyperhidrosis (BBI-4000-CL-302)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":351,"lead_sponsor_name":"Botanix Pharmaceuticals","has_results":true},{"nct_id":"NCT03836287","title":"Safety and Efficacy Study of Sofpironium Bromide in Subjects With Axillary Hyperhidrosis (BBI-4000-CL-301)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":350,"lead_sponsor_name":"Botanix Pharmaceuticals","has_results":true},{"nct_id":"NCT03627468","title":"A Safety Study of BBI-4000 Gel in Patients With Axillary Hyperhidrosis","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":300,"lead_sponsor_name":"Botanix Pharmaceuticals","has_results":true},{"nct_id":"NCT03024255","title":"A Confirmatory Safety and Efficacy Study of BBI-4000 in Subjects With Axillary Hyperhidrosis","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":227,"lead_sponsor_name":"Botanix Pharmaceuticals","has_results":true},{"nct_id":"NCT03760198","title":"Evaluate the Efficacy and Safety of MEDITOXIN in Treatment of Primary Axillary Hyperhidrosis","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":220,"lead_sponsor_name":"Medy-Tox","has_results":false},{"nct_id":"NCT05108103","title":"Determination of Longus Colli Muscle Thickness by Ultrasonography","phase":"","overall_status":"COMPLETED","enrollment_count":200,"lead_sponsor_name":"Istanbul University","has_results":false},{"nct_id":"NCT02336503","title":"A Safety and Efficacy Study of BBI-4000 in Subjects With Axillary Hyperhidrosis","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":189,"lead_sponsor_name":"Botanix Pharmaceuticals","has_results":true},{"nct_id":"NCT02479139","title":"Clinical Trial To Evaluate ANT-1207 In Participants With Primary Axillary Hyperhidrosis","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":145,"lead_sponsor_name":"Allergan","has_results":true},{"nct_id":"NCT06219655","title":"Extended Versus Limited Thoracoscopic Sympathectomy: Its Impact on Palmar and Plantar Hyperhidrosis","phase":"NA","overall_status":"COMPLETED","enrollment_count":120,"lead_sponsor_name":"Mansoura University","has_results":false},{"nct_id":"NCT04599907","title":"Evaluation of N-SWEAT Patch for Treatment of Primary Axillary Hyperhidrosis or Excessive Axillary Sweating","phase":"NA","overall_status":"COMPLETED","enrollment_count":120,"lead_sponsor_name":"Candesant Biomedical, Inc.","has_results":true},{"nct_id":"NCT04906655","title":"An Open Label Study for Palmar Hyperhydrosis","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":120,"lead_sponsor_name":"Pariser, Robert J., M.D.","has_results":false},{"nct_id":"NCT04546438","title":"Patient Satisfaction and Safety of Miradry Treatment for Axillary Hyperhidrosis","phase":"NA","overall_status":"COMPLETED","enrollment_count":100,"lead_sponsor_name":"Region Östergötland","has_results":false},{"nct_id":"NCT03416348","title":"Hyperhidrosis, Developing a Treatment Approach Aims 1 & 2","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":95,"lead_sponsor_name":"University of Utah","has_results":false},{"nct_id":"NCT07094009","title":"Comparison of the Clinical Efficacy and Adverse Reactions of Different Needling Patterns of High-frequency Microneedles in the Treatment of Axillary Odor","phase":"NA","overall_status":"COMPLETED","enrollment_count":90,"lead_sponsor_name":"First Affiliated Hospital of Chongqing Medical University","has_results":false},{"nct_id":"NCT03840655","title":"Fluorescent Thoracoscopy Used in Surgery for Palmar Hyperhidrosis","phase":"","overall_status":"COMPLETED","enrollment_count":89,"lead_sponsor_name":"Peking University People's Hospital","has_results":false},{"nct_id":"NCT03880266","title":"A Study of Glycopyrronium Cloth, 2.4% in Patients With Palmar Hyperhidrosis","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":72,"lead_sponsor_name":"Journey Medical Corporation","has_results":true},{"nct_id":"NCT03404570","title":"Exploratory Study to Assess the Efficacy and Safety of TC-5214 in the Treatment of Subjects With Palmar Hyperhidrosis","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":60,"lead_sponsor_name":"Atacama Therapeutics","has_results":false},{"nct_id":"NCT05875285","title":"Methotrexate Iontophoresis Versus Coal Tar Ointement in the Treatment of Primary Palmer Hyper Hidrosis","phase":"NA","overall_status":"UNKNOWN","enrollment_count":60,"lead_sponsor_name":"Cairo University","has_results":false},{"nct_id":"NCT06645509","title":"Severe Primary Hand Hyperhidrosis Treatment With Topical Administration of Victorhy","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":58,"lead_sponsor_name":"Dryox Health","has_results":false},{"nct_id":"NCT02673619","title":"A Study to Evaluate Clinical Effect, Pharmacokinetics , Safety, and Tolerability of Umeclidinium in Palmar Hyperhidrosis Subjects","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":58,"lead_sponsor_name":"Stiefel, a GSK Company","has_results":true},{"nct_id":"NCT06532045","title":"Effect of TENS on Patients With Palmar Hyperhidrosis","phase":"NA","overall_status":"TERMINATED","enrollment_count":56,"lead_sponsor_name":"Cairo University","has_results":false},{"nct_id":"NCT02682238","title":"A Safety, Tolerability and Preliminary Efficacy Study of BBI-4000 Gel in Subjects With Palmar Hyperhidrosis","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":50,"lead_sponsor_name":"Botanix Pharmaceuticals","has_results":true},{"nct_id":"NCT07196319","title":"\"Incidence of Compensatory Hyperhidrosis After T3 Vs T3-4 Sympathectomy\"","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":46,"lead_sponsor_name":"Assiut University","has_results":false},{"nct_id":"NCT06731101","title":"Stellate Ganglion Block Versus Oral Medication in Treatment of Palmar Hyperhidrosis","phase":"NA","overall_status":"COMPLETED","enrollment_count":46,"lead_sponsor_name":"Fayoum University","has_results":false},{"nct_id":"NCT05863104","title":"Assessment of Safety, Tolerability, Systemic Exposure and Efficacy of GPB Cream in Adolescents With Severe Primary Hyperhidrosis","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":44,"lead_sponsor_name":"Dr. August Wolff GmbH & Co. KG Arzneimittel","has_results":false},{"nct_id":"NCT04721483","title":"T3-T4 Gray Sympathycotomy Versus Ramicotomy for Hyperhidrosis","phase":"NA","overall_status":"COMPLETED","enrollment_count":42,"lead_sponsor_name":"University of Valencia","has_results":false},{"nct_id":"NCT03694093","title":"Assessing the Effect of Patient Characteristics on Treatment Response in Primary Hyperhidrosis","phase":"","overall_status":"COMPLETED","enrollment_count":41,"lead_sponsor_name":"St. Louis University","has_results":false},{"nct_id":"NCT03054480","title":"Fractional Micro-Needle Radiofrequency and I Botulinum Toxin A for Primary Axillary Hyperhidrosis","phase":"NA","overall_status":"COMPLETED","enrollment_count":40,"lead_sponsor_name":"Mae Fah Luang University Hospital","has_results":false},{"nct_id":"NCT04862546","title":"Laser Acupuncture Versus Tap Water Iontophoresis on Hyperhidrosis","phase":"NA","overall_status":"COMPLETED","enrollment_count":40,"lead_sponsor_name":"Kafrelsheikh University","has_results":false},{"nct_id":"NCT05057117","title":"Longevity of Microwave Thermolysis and Botulinum Toxin A for Treatment of Axillary Hyperhidrosis","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":30,"lead_sponsor_name":"Merete Haedersdal","has_results":false},{"nct_id":"NCT06881394","title":"A Polymer Film Device to Treat Excessive Palmar Sweating","phase":"NA","overall_status":"RECRUITING","enrollment_count":30,"lead_sponsor_name":"Miller Biosciences LLC","has_results":false},{"nct_id":"NCT02563899","title":"Pharmacokinetic, Safety, Tolerability, and Clinical Effect of Topical Umeclidinium in Primary Axillary Hyperhidrosis","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":28,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT03236012","title":"Hyperhidrosis in Patients With Amputations-Botox","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":25,"lead_sponsor_name":"University of Utah","has_results":false},{"nct_id":"NCT03785587","title":"A Safety Study of BBI-4000 Gel in Pediatric Patients With Axillary Hyperhidrosis","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":21,"lead_sponsor_name":"Botanix Pharmaceuticals","has_results":true},{"nct_id":"NCT04227691","title":"Treatment of Axillary Hyperhidrosis With Long-pulsed Nd:YAG Laser or IPL","phase":"NA","overall_status":"UNKNOWN","enrollment_count":20,"lead_sponsor_name":"Zealand University Hospital","has_results":false},{"nct_id":"NCT03320096","title":"Evaluation of the Ulthera System for Treating Axillary Hyperhidrosis","phase":"NA","overall_status":"COMPLETED","enrollment_count":20,"lead_sponsor_name":"Ulthera, Inc","has_results":true},{"nct_id":"NCT05805696","title":"Treatment and Mapping of Impostor Phenomenon","phase":"NA","overall_status":"RECRUITING","enrollment_count":20,"lead_sponsor_name":"Umeå University","has_results":false},{"nct_id":"NCT02823340","title":"Fractionated Microneedle Radiofrequency for Treatment of Primary Axillary Hyperhidrosis","phase":"NA","overall_status":"COMPLETED","enrollment_count":20,"lead_sponsor_name":"Xijing Hospital","has_results":false},{"nct_id":"NCT05403710","title":"Botulinum Toxin Therapy in Hidradenitis Suppurativa","phase":"","overall_status":"RECRUITING","enrollment_count":20,"lead_sponsor_name":"University of Massachusetts, Worcester","has_results":false},{"nct_id":"NCT01934153","title":"Characterization of Exposure From Topical Administration of [14C] Umeclidinium to Axilla or Palm of Healthy Male Subjects","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":18,"lead_sponsor_name":"GlaxoSmithKline","has_results":false},{"nct_id":"NCT05102396","title":"Topical Oxybutynin for Treatment of Hyperidrosis: Local or Systemic Effect?","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":17,"lead_sponsor_name":"Samantha Rodrigues Camargo Neves de Moura","has_results":false},{"nct_id":"NCT03816046","title":"Hyperhydrosis Treatment Using Botulinum Toxin","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":15,"lead_sponsor_name":"St Joseph University, Beirut, Lebanon","has_results":false},{"nct_id":"NCT04924036","title":"Qbrexza Cloths for Hyperhidrosis of Amputation Sites","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":13,"lead_sponsor_name":"University of Utah","has_results":true},{"nct_id":"NCT03647982","title":"Anhidrotic Area and Safety of MEDITOXIN in Healthy Male Valunteers","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":13,"lead_sponsor_name":"Medy-Tox","has_results":false},{"nct_id":"NCT05501444","title":"Antiperspirant in the Treatment of Residual Limp Hyperhidrosis for Prosthetic Users","phase":"NA","overall_status":"COMPLETED","enrollment_count":7,"lead_sponsor_name":"Sophies Minde Ortopedi","has_results":false}],"total":48},"guidelines":[],"source":"Drug Landscape verified database"}